Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa D Aimone

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitorsRabindranath Tripathy, Arup Ghose, Jasbir Singh, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2011
4,5-dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonistsRobert L Hudkins, Lisa D Aimone, Reddeppa Reddy Dandu, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2012
Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activityBabu G Sundar, Thomas R Bailey, Derek Dunn, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activityRobert L Hudkins, Allison L Zulli, Reddeppa reddy Dandu, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2011
Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitorsCraig A Zificsak, Jay P Theroff, Lisa D Aimone, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2010
8-THP-DHI analogs as potent Type I dual TIE-2/VEGF-R2 receptor tyrosine kinase inhibitorsRobert L Hudkins, Allison L Zulli, Ted L Underiner, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2008
Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinasesReddeppareddy Dandu, Allison L Zulli, Edward R Bacon, et al.
Chemical Research in Toxicology|October 26, 2011
2,7-Disubstituted-pyrrolotriazine kinase inhibitors with an unusually high degree of reactive metabolite formationKevin J Wells-Knecht, Gregory R Ott, Mangeng Cheng, et al.
Journal of Medicinal Chemistry|June 4, 2011
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonistRobert L Hudkins, Rita Raddatz, Ming Tao, et al.
Molecular Cancer Therapeutics|December 29, 2011
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancersMangeng Cheng, Matthew R Quail, Diane E Gingrich, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitorsRabindranath Tripathy, Arup Ghose, Jasbir Singh, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2011
4,5-dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonistsRobert L Hudkins, Lisa D Aimone, Reddeppa Reddy Dandu, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2012
Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activityBabu G Sundar, Thomas R Bailey, Derek Dunn, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activityRobert L Hudkins, Allison L Zulli, Reddeppa reddy Dandu, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2011
Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitorsCraig A Zificsak, Jay P Theroff, Lisa D Aimone, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2010
8-THP-DHI analogs as potent Type I dual TIE-2/VEGF-R2 receptor tyrosine kinase inhibitorsRobert L Hudkins, Allison L Zulli, Ted L Underiner, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2008
Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinasesReddeppareddy Dandu, Allison L Zulli, Edward R Bacon, et al.
Chemical Research in Toxicology|October 26, 2011
2,7-Disubstituted-pyrrolotriazine kinase inhibitors with an unusually high degree of reactive metabolite formationKevin J Wells-Knecht, Gregory R Ott, Mangeng Cheng, et al.
Journal of Medicinal Chemistry|June 4, 2011
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonistRobert L Hudkins, Rita Raddatz, Ming Tao, et al.
Molecular Cancer Therapeutics|December 29, 2011
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancersMangeng Cheng, Matthew R Quail, Diane E Gingrich, et al.
Pageof 5